Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
Conditions:   Ovarian Cancer Stage IV;   Ovarian Cancer Stage III Intervention:   Sponsors:   Jing Li;   Nanjing Shihejiyin Technology, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2023 Category: Research Source Type: clinical trials